Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FJM53
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,526
Award facts
- Contract value 100% obligated
- $26,525.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,525.70 to AmerisourceBergen Drug Corp for the supply of IMFINZI (durvalumab) 500 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive pharmaceutical supply vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and a critical federal medical procurement vendor, particularly for the Defense Logistics Agency's medical supply chain. The company's existing IDC with DLA enables it to supply an extensive portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support defense health operations. This particular delivery order for IMFINZI, an oncology medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FJM53?
SPE2DB25FJM53 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FJM53 worth?
The government has obligated $26,526 on SPE2DB25FJM53.
Is contract SPE2DB25FJM53 an order under another contract?
Yes. SPE2DB25FJM53 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJM53 competed?
The extent of competition for SPE2DB25FJM53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award